Testers are required to “acknowledge the confidentiality of the process” in order to gain access to the testing environment, according to The Wall Street Journal. Meanwhile, The New York Times reports on two studies that examine the health law’s drug plans as a means to answer questions about how the overhaul is working.

Original post:
CMS directs insurers to begin testing but maintain confidentiality

Scroll to Top